A Christchurch medtech startup is seeking at least $1.5m to turn University of Canterbury insulin pump research into a commercial device.
Christchurch medtech startup Zuuka is seeking at least 1.5 million at a $10m pre-money valuation as it works to commercialise insulin pump technology developed through University of Canterbury research.
Find the full article here.
MedTech Company
When Cannulight’s founder was studying dentistry, he noticed a small but important problem – he decided to make it his mission to fix it with a simple-yet-elegant solution.
MedTech Company
Auckland’s HeartLab, which uses AI to speed analysis of heart scans, has won a contract for its technology to be used in Australia’s largest cardiology chain.
NZ Medtech Scene
A New Zealand medtech startup is preparing to commercialise a world-first wearable drug-delivery platform to help address growing global concerns around long-term adherence to diabetes, obesity, Parkinson’s and Alzheimer’s treatments. Christchurch-based Zuuka is raising capital to fund prototype development and regulatory submissions for entry into the United States, following a wave of recent FDA clearances extending automated insulin pump therapy to type 2 diabetes - a change expected to bring millions of additional patients into the market for wearable insulin delivery devices.